| LPS-induced upregulation of SHIP is essential for endotoxin tolerance LM Sly, MJ Rauh, J Kalesnikoff, CH Song, G Krystal Immunity 21 (2), 227-239, 2004 | 379 | 2004 |
| SHIP represses the generation of alternatively activated macrophages MJ Rauh, V Ho, C Pereira, A Sham, LM Sly, V Lam, L Huxham, ... Immunity 23 (4), 361-374, 2005 | 337 | 2005 |
| SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts S Takeshita, N Namba, JJ Zhao, Y Jiang, HK Genant, MJ Silva, MD Brodt, ... Nature medicine 8 (9), 943-949, 2002 | 292 | 2002 |
| Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis MA Webster, JN Hutchinson, MJ Rauh, SK Muthuswamy, M Anton, ... Molecular and cellular biology 18 (4), 2344-2359, 1998 | 252 | 1998 |
| Tet2 restrains inflammatory gene expression in macrophages AH Cull, B Snetsinger, R Buckstein, RA Wells, MJ Rauh Experimental hematology 55, 56-70. e13, 2017 | 243 | 2017 |
| The Hippo pathway component TAZ promotes immune evasion in human cancer through PD-L1 HJ Janse van Rensburg, T Azad, M Ling, Y Hao, B Snetsinger, P Khanal, ... Cancer research 78 (6), 1457-1470, 2018 | 242 | 2018 |
| Randomized phase II study of azacitidine alone or in combination with lenalidomide or with vorinostat in higher-risk myelodysplastic syndromes and chronic myelomonocytic … MA Sekeres, M Othus, AF List, O Odenike, RM Stone, SD Gore, MR Litzow, ... Journal of Clinical Oncology 35 (24), 2745, 2017 | 236 | 2017 |
| An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis SO Abegunde, R Buckstein, RA Wells, MJ Rauh Experimental hematology 59, 60-65, 2018 | 177 | 2018 |
| SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide LM Sly, MJ Rauh, J Kalesnikoff, T Büchse, G Krystal Experimental hematology 31 (12), 1170-1181, 2003 | 150 | 2003 |
| The role of SHIP in cytokine-induced signaling J Kalesnikoff, LM Sly, MR Hughes, T Büchse, MJ Rauh, LP Cao, V Lam, ... Reviews of physiology, biochemistry and pharmacology, 87-103, 2004 | 139 | 2004 |
| SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils E Kuroda, V Ho, J Ruschmann, F Antignano, M Hamilton, MJ Rauh, ... The Journal of Immunology 183 (6), 3652-3660, 2009 | 128 | 2009 |
| Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis EK Cook, T Izukawa, S Young, G Rosen, M Jamali, L Zhang, D Johnson, ... Blood advances 3 (16), 2482-2486, 2019 | 108 | 2019 |
| The role of SHIP1 in macrophage programming and activation MJ Rauh, LM Sly, J Kalesnikoff, MR Hughes, LP Cao, V Lam, G Krystal Biochemical Society Transactions 32 (5), 785-788, 2004 | 105 | 2004 |
| Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review MJ Rauh, F Rahman, D Good, J Silverman, MK Brennan, N Dimov, ... Leukemia research 36 (1), 81-86, 2012 | 104 | 2012 |
| Clonal hematopoiesis is associated with risk of severe Covid-19 KL Bolton, Y Koh, MB Foote, H Im, J Jee, CH Sun, A Safonov, R Ptashkin, ... Nature communications 12 (1), 5975, 2021 | 97 | 2021 |
| Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity EK Cook, M Luo, MJ Rauh Experimental hematology 83, 85-94, 2020 | 97 | 2020 |
| Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension F Potus, MW Pauciulo, EK Cook, N Zhu, A Hsieh, CL Welch, Y Shen, ... Circulation 141 (24), 1986-2000, 2020 | 92 | 2020 |
| The role of SHIP in macrophages LM Sly, V Ho, F Antignano, J Ruschmann, M Hamilton, V Lam, MJ Rauh, ... Front Biosci 12 (8-12), 2836-2848, 2007 | 91 | 2007 |
| Role of Src homology 2-containing-inositol 5′-phosphatase (SHIP) in mast cells and macrophages MJ Rauh, J Kalesnikoff, M Hughes, L Sly, V Lam, G Krystal Biochemical Society Transactions 31 (1), 286-291, 2003 | 83 | 2003 |
| Genomic biomarkers to predict resistance to hypomethylating agents in patients with myelodysplastic syndromes using artificial intelligence A Nazha, MA Sekeres, R Bejar, MJ Rauh, M Othus, RS Komrokji, ... JCO precision oncology 3, 1-11, 2019 | 55 | 2019 |
